Literature DB >> 10692084

Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentrations and haemostatic factors in healthy individuals.

F Parente1, V Imbesi, C Cucino, G MacOni, U Russo, P G Duca, G Bianchi Porro.   

Abstract

BACKGROUND: H. pylori CagA seropositivity has been recently associated with ischaemic heart disease.
OBJECTIVE: To evaluate whether H. pylori virulence has any effect on certain circulating coagulation factors and on markers of systemic inflammation in healthy individuals.
DESIGN: Prospective cohort study.
SETTING: Haematology and gastroenterology unit at a university teaching hospital.
SUBJECTS: A total of 494 consecutive asymptomatic blood donors attending a blood bank. MEASUREMENTS: Blood analysis for haemostatic factors, lipids concentrations, inflammatory parameters as well as determination of anti H. pylori IgG and CagA reactivity by ELISA assayes.
RESULTS: The overall prevalence of H. pylori infection was 53%; 56% of H. pylori positive sera expressed CagA reactivity. CagA seropositive subjects did not differ significantly from CagA negative or H. pylori negative subjects in values for lipids, haemostatic factors, or inflammatory parameters.
CONCLUSIONS: CagA seropositivity is not associated with increased systemic inflammation or with raised concentrations of haemostatic factors - predictors of ischaemic heart disease - in healthy individuals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692084     DOI: 10.1046/j.1365-2796.2000.00601.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  2 in total

1.  Reply to the letter to the editor: H. pylori test-and-treat should not be put off for gastric cancer prevention in East Asia any longer.

Authors:  Hideki Mori; Hidekazu Suzuki
Journal:  J Gastroenterol       Date:  2018-06       Impact factor: 7.527

2.  Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters.

Authors:  Seung Ha Park; Woo Kyu Jeon; Sang Hoon Kim; Hong Joo Kim; Dong Il Park; Yong Kyun Cho; In Kyung Sung; Chong Il Sohn; Byung Ik Kim; Dong Keuk Keum
Journal:  J Natl Med Assoc       Date:  2005-04       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.